Status:
COMPLETED
Effectiveness of Bupropion for Treating Nicotine Dependence in Young People
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Tobacco Use Cessation
Tobacco Use Disorder
Eligibility:
All Genders
12-25 years
Phase:
PHASE2
Brief Summary
Little is known about the best ways to help young people stop smoking. Bupropion (a medication marketed as Wellbutrin or Zyban) has proved helpful in treating adult smokers. The purpose of this study ...
Detailed Description
Cigarette smoking and other forms of tobacco exposure are one of the leading preventable causes of morbidity and mortality in the United States. Most smokers begin smoking during adolescence, and thou...
Eligibility Criteria
Inclusion
- Has smoked at least 10 cigarettes each day for 3 or more months
- Weighs at least 90 lbs
- Motivated to quit smoking and has had at least one previous failed attempt
- Speaks, reads, and writes English
- Either diagnosed as depressed OR no history of a psychiatric disorder
Exclusion
- History of bipolar disorder, eating disorder, schizophrenia, schizoaffective disorder, autism, or non-nicotine substance use disorder in the 6 months prior to study entry
- Currently suicidal or with a history of a suicide attempt in the 6 months prior to study entry
- Psychotic symptoms
- Use of psychotropic medication(s)
- Serious medical condition
- Prior use of bupropion for smoking cessation
- Currently using other smoking cessation treatments
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT00129272
Start Date
May 1 2004
End Date
January 1 2011
Last Update
May 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75390 9101